Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
Suzetrigine, now marketed as Journavx, is not the first sodium-channel-targeting drug for pain management. Compounds such as procaine (Novocain) have provided reliable anaesthesia for more than a ...